Title: Venture Investment Bank for Early Stage Technology Companies
1(No Transcript)
2Who We Are
- Venture Investment Bank for Early Stage
Technology Companies - We Invest Through
- Angel Institutional Investor Members
- Capital Managed Internally
- NASD\Broker Dealer
3The Fact is
- VCs Dont Invest in Early Stage Companies
- Angels Do!
4Early Stage
- Seed A Round B Rounds Mezzanine
IPO/Exit
Capital Chasm
200k .5 5M 10M
10 - 30M 40M
5Ten Highly Effective Habits of Successful Angel
Investing
6Ten Highly Effective Habits of Successful Angel
Investing
- 2. Be Quick but dont Hurry
7Ten Highly Effective Habits of Successful Angel
Investing
- 3. Invest in Deals you Understand
8Ten Highly Effective Habits of Successful Angel
Investing
- 4. Dont try to change the Company
9Ten Highly Effective Habits of Successful Angel
Investing
- 5. Do your own Competitive Analysis Research
10Ten Highly Effective Habits of Successful Angel
Investing
- 6. Get to KNOW the Customer
11Ten Highly Effective Habits of Successful Angel
Investing
- 7. Really get to KNOW the Team
12Ten Highly Effective Habits of Successful Angel
Investing
- 8. Never, ever Fall in Love
13Ten Highly Effective Habits of Successful Angel
Investing
- 9. Know the Intellectual Property
14Ten Highly Effective Habits of Successful Angel
Investing
- 10. Know who you pass the Baton to before you
invest
15Superior Deal Selection Superior Deal Support
16Deal Selection Process
- Initial Screening by Angel Capital Staff
- Qualified Deals go to Expert Angel
- Members for Analysis
- Engage VCs in Due Diligence Review
- Engage Relevant Strategic Investors
17Deal Selection Criteria
- Angel Investors with Deep Relevant Industry
Experience Willing to - Invest
- Serve as Advisors
- VCs Willing to Fund Later Rounds Based on Certain
Milestones - Defensible IP
18Deal Support
- Introduce
- Expert Angels Who Invest and Join Board
- Industry Board Members
- Strategic Relationships
- VCs with Relevant Expertise
- Valuation and Deal Structure
- Ongoing Corporate Finance Services
19- Disruptive Technology in Intelligent Storage
Networks - 12 patents filed, more to come
- Market projected to grow 900 by 2003 to 6.7B
- Experienced management team has built two
successful companies - Elite industry board
- Key industry relationships in place
20BioRight International, Inc.
- Breakthrough Nonprescription Cold
- Allergy Medicines
- Launched 11/00 - Sales Exceeding 1.3 Million
- Distribution in Over 22,000 Retail Pharmacies
Walgreens, Rite-Aid, Eckerds, Safeway, Osco,
Longs - Pipeline for New Product Introductions
- Revenue Growth to Over 100 Million Within 5
Years - Management Combines Medical Expertise With 25
Year Track Record of Retail Product Introductions
21- Multifocal Contact Lens With Strong Patents and
High Consumer Demand - Clinical Data Consistently Outperforms Any Lens
on the Market (Including JJ Acuvue) - FDA Approval Received for
- Custom (Lathed Lens) Launched in US and Canada
- Cast Molded Lens (Disposable Mass Produced)
- CE Mark Received for Astigmatic Intraocular Lens
22Contact Information
- Mike Pogue - President
- (415) 289-4618
- mpogue_at_angelcapitalnetwork.com
23(No Transcript)